Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05472545 · ClinicalTrials.gov registry record · NA
Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth
A NA study of Emotional Regulation, sponsored by Oklahoma State University Center for Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT05472545: Active NA study of Emotional Regulation, sponsored by Oklahoma State University Center for Health Sciences.
NCT05472545 is a NA study of Emotional Regulation that is active but no longer recruiting, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 210 participants, below the 458-participant average among 11 other Emotional Regulation trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05472545, a NA study of Emotional Regulation, is active but no longer recruiting, sponsored by Oklahoma State University Center for Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.
Primary Outcome
Activation in the right anterior insular cortex and associated regions. We hypothesize that lower activity will indicate a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Neurofeedback
Study Locations (1)
Oklahoma
- Hardesty Center for Clinical Research and Neuroscience - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2025-09 |
| Phase | NA |
What the registry record for NCT05472545 still lists
NCT05472545 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 458-participant average among 11 other Emotional Regulation trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Emotional Regulation appearing as the primary indexed condition, and to 1 intervention - of which Neurofeedback is the first listed.
NCT05472545 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05472545 about?
NCT05472545 is a clinical study titled "Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth". This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while ta...
What is the current status of trial NCT05472545?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2023-03-13. Estimated completion is 2025-09.
What conditions does trial NCT05472545 study?
This clinical trial studies the following conditions: Emotional Regulation.
What interventions are being tested in trial NCT05472545?
The interventions under investigation include: Neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05472545?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05472545 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotional Regulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05472545's enrollment target sits among peer trials
210 5th of 11 higher than 7 of 11 other Emotional Regulation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emotional Regulation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
-
Students With Involved Families and Teachers
RECRUITING · NA
-
The STRENGTHEN Study
RECRUITING · NA
-
Improving Minority Health Through Biofeedback and Stress Reduction
RECRUITING · NA
-
An Intervention to Enhance Well-Being in Trauma Exposed New Mothers
ACTIVE NOT RECRUITING · NA
-
An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI